Unknown NA INTERVENTIONAL NCT00809029

The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study

The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Hormone Sensitive Lipase, Lipoprotein Lipase And Adipokine Expression In Human Subcutaneous Adipose Tissue: An In Vivo Study

Sponsor: Liverpool University Hospitals NHS Foundation Trust

Conditions Adipose Tissue

Interventions GIP (glucose dependent insulinotropic peptide) infusion

Updated 6 times since 2017 Last updated: Dec 20, 2011 Started: Apr 30, 2011 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Adipose Tissue, this trial is ongoing. The trial is conducted by Liverpool University Hospitals NHS Foundation Trust and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA
Jun 2018 — Feb 2020 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Liverpool University Hospitals NHS Foundation Trust

Data source: Liverpool University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Liverpool, United Kingdom